Evidence map›Paper›PMID 36026527›Full record

ArticlePLoS medicine2022

Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.

Aaloke Mody, Cory Bradley, Salil Redkar, Branson Fox, Ingrid Eshun-Wilson, Matifadza G Hlatshwayo, Anne Trolard, Khai Hoan Tram, Lindsey M Filiatreau, Franda Thomas and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Interventions to Improve COVID-19 Vaccine Hesitancy.Rheumatic diseases clinics of North America · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Using Rapid-Cycle Change to Improve COVID-19 Vaccination Strategy in Primary Care.International journal of environmental research and public health · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Aaloke ModyWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0003-3787-365X
Cory BradleyWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-3856-8211
Salil RedkarWashington University School of Medicine, St. Louis, Missouri, United States of America.
Branson FoxWashington University School of Medicine, St. Louis, Missouri, United States of America.
Ingrid Eshun-WilsonWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-4049-9868
Matifadza G HlatshwayoSt. Louis City Department of Health, St. Louis, Missouri, United States of America.
Anne TrolardWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0001-9922-9208
Khai Hoan TramUniversity of Washington School of Medicine, Seattle, Washington, United States of America.ORCID 0000-0003-1129-7674
Lindsey M FiliatreauWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-0355-4477
Franda ThomasSt. Louis City Department of Health, St. Louis, Missouri, United States of America.
Matt HaslamSt. Louis City Department of Health, St. Louis, Missouri, United States of America.ORCID 0000-0001-5922-9334
George TurabelidzeMissouri Department of Health and Senior Services, Jefferson City and St Louis, Missouri, United States of America.ORCID 0000-0001-5401-3550
Vetta Sanders-ThompsonBrown School of Social Work, Washington University in St. Louis, St. Louis, Missouri, United States of America.ORCID 0000-0002-0415-9196
William G PowderlyWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0001-7808-3086
Elvin H GengWashington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-0825-1424
Washington University in St. Louis · USMissouri Department of Health and Senior Services · USUniversity of Washington · US

Funding

HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
NCATS NIH HHS KL2 TR002346NIAID NIH HHS K24 AI134413NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

backgroundEquity in vaccination coverage is a cornerstone for a successful public health response to COVID-19. To deepen understanding of the extent to which vaccination coverage compares with initial strategies for equitable vaccination, we explore primary vaccine series and booster rollout over time and by race/ethnicity, social vulnerability, and geography. METHODS AND

findingsWe analyzed data from the Missouri Department of Health and Senior Services on all COVID-19 vaccinations administered across 7 counties in the St. Louis region and 4 counties in the Kansas City region. We compared rates of receiving the primary COVID-19 vaccine series and boosters relative to time, race/ethnicity, zip-code-level Social Vulnerability Index (SVI), vaccine location type, and COVID-19 disease burden. We adapted a well-established tool for measuring inequity-the Lorenz curve-to quantify inequities in COVID-19 vaccination relative to these key metrics. Between 15 December 2020 and 15 February 2022, 1,763,036 individuals completed the primary series and 872,324 received a booster. During early phases of the primary series rollout, Black and Hispanic individuals from high SVI zip codes were vaccinated at less than half the rate of White individuals from low SVI zip codes, but rates increased over time until they were higher than rates in White individuals after June 2021; Asian individuals maintained high levels of vaccination throughout. Increasing vaccination rates in Black and Hispanic communities corresponded with periods when more vaccinations were offered at small community-based sites such as pharmacies rather than larger health systems and mass vaccination sites. Using Lorenz curves, zip codes in the quartile with the lowest rates of primary series completion accounted for 19.3%, 18.1%, 10.8%, and 8.8% of vaccinations while representing 25% of the total population, cases, deaths, or population-level SVI, respectively. When tracking Gini coefficients, these disparities were greatest earlier during rollout, but improvements were slow and modest and vaccine disparities remained across all metrics even after 1 year. Patterns of disparities for boosters were similar but often of much greater magnitude during rollout in fall 2021. Study limitations include inherent limitations in the vaccine registry dataset such as missing and misclassified race/ethnicity and zip code variables and potential changes in zip code population sizes since census enumeration.

conclusionsInequities in the initial COVID-19 vaccination and booster rollout in 2 large US metropolitan areas were apparent across racial/ethnic communities, across levels of social vulnerability, over time, and across types of vaccination administration sites. Disparities in receipt of the primary vaccine series attenuated over time during a period in which sites of vaccination administration diversified, but were recapitulated during booster rollout. These findings highlight how public health strategies from the outset must directly target these deeply embedded structural and systemic determinants of disparities and track equity metrics over time to avoid perpetuating inequities in healthcare access.

Indexed as

COVID-19EthnicityCOVID-19 VaccinesHumansKansasMissouriSocial VulnerabilityCOVID-19 Vaccines

Identifiers

PMID36026527
PMCPMC9417193
OpenAlexW4293155653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.